Business
Currency:CNY
2024/H1
Stock NameRevenueRatio
销售眼科产品150.01M89.49%
医药产品推广服务11.86M7.07%
合约开发及生产服务3.46M2.06%
以销售为基础的特许权使用费收入2.29M1.37%
Product
No Data
Region
No Data